Company profile: Phasefocus
1.1 - Company Overview
Company description
- Provider of Virtual Lens and ptychographic imaging technologies that generate high-definition amplitude and phase images without high-quality lenses for optical, X-ray and electron microscopy. Products include Livecyte, a label-free system to track and analyze live cell behavior, and πBox, a ptychographic reconstruction engine for electron microscopy.
Products and services
- Virtual Lens: Proprietary algorithmic imaging technology that generates high-definition amplitude and phase images without high-quality lenses, using a novel iterative phase retrieval, applicable to optical, X-ray, and electron microscopy
- Livecyte: Label-free ptychographic quantitative phase imaging system that tracks and analyzes live cell behavior—including proliferation, motility, and morphology—without fluorescent labels, architected for quantitative characterization of living cells
- πBox for Electron Microscopy: Computational reconstruction engine for ptychographic processing that converts raw diffraction pattern data into ptychographic reconstructions, compatible with various wavelengths and particle beams across modalities
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Phasefocus
IntelliCyt
HQ: United States
Website
- Description: Provider of high-throughput cell and bead-based screening solutions for use throughout the life sciences, leveraging proprietary technologies to deliver instrumentation, reagent kits, and software that increase the speed and reduce the cost of detecting and measuring cells.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full IntelliCyt company profile →
Newomics
HQ: United States
Website
- Description: Provider of integrative platforms for personalized healthcare, offering mass spectrometry and LC-MS solutions including DuoESI Source (dual ion source enhancing ionization for multiomics, compatible with leading mass spectrometers), MEA Chip (silicon LC column/ESI emitter/post-column inlet chip for improved sensitivity and robustness in proteomics), and M3 Emitter (silicon microfluidic flow-splitting emitter for enhanced ionization).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Newomics company profile →
Ziylo
HQ: United Kingdom
Website
- Description: Provider of biomimetic glucose binding molecules (GBM) based on supramolecular chemistry for use in diabetes care, enabling Continuous Glucose Monitors (CGM) and Glucose Responsive Insulins (GRI), with a mission to help people with diabetes live more normal and longer lives.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ziylo company profile →
Cardea Bio
HQ: United States
Website
- Description: Provider of graphene-based, biology-gated transistor infrastructure and biosensing solutions, including: BPU Platform converting biological interactions into electrical signals for real-time multiomics; graphene biosensors for direct biomolecule measurement; CRISPR-Chip for gene editing efficiency; and commercial/research partnerships across healthcare, agriculture, and environmental monitoring.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cardea Bio company profile →
Lextox
HQ: United Kingdom
Website
- Description: Provider of hair drug and alcohol, blood alcohol, DNA, and SCRAM continuous alcohol testing for family law cases and child care proceedings. Operates a hair drug and alcohol testing laboratory and is a member of the SYNLAB Group. Customers can contact via phone, mail, and social media.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lextox company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Phasefocus
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Phasefocus
2.2 - Growth funds investing in similar companies to Phasefocus
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Phasefocus
4.2 - Public trading comparable groups for Phasefocus
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →